Rona D. Yaeger
Memorial Sloan Kettering Cancer Center · 896 works · 36,285 citations · h-index 75
Top works
- Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
- Tumor mutational load predicts survival after immunotherapy across multiple cancer types
- Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer
- OncoKB: A Precision Oncology Knowledge Base
- PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer
- Encorafenib, Binimetinib, and Cetuximab in BRAF V600E–Mutated Colorectal Cancer
- Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy
- Clinical Sequencing Defines the Genomic Landscape of Metastatic Colorectal Cancer
- Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer
- Microsatellite Instability Is Associated With the Presence of Lynch Syndrome Pan-Cancer
- Assessment of a Watch-and-Wait Strategy for Rectal Cancer in Patients With a Complete Response After Neoadjuvant Therapy
- Combined BRAF, EGFR, and MEK Inhibition in Patients with BRAF V600E-Mutant Colorectal Cancer
- Tumours with class 3 BRAF mutants are sensitive to the inhibition of activated RAS
- Encorafenib Plus Cetuximab as a New Standard of Care for Previously Treated BRAF V600E–Mutant Metastatic Colorectal Cancer: Updated Survival Results and Subgroup Analyses from the BEACON Study
- Reliable Detection of Mismatch Repair Deficiency in Colorectal Cancers Using Mutational Load in Next-Generation Sequencing Panels
- EGFR Blockade Reverts Resistance to KRASG12C Inhibition in Colorectal Cancer
- Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C
- Comparative sequencing analysis reveals high genomic concordance between matched primary and metastatic colorectal cancer lesions
- Loss of NF1 in Cutaneous Melanoma Is Associated with RAS Activation and MEK Dependence
- Pilot Trial of Combined BRAF and EGFR Inhibition in BRAF -Mutant Metastatic Colorectal Cancer Patients